Patient Satisfaction in Mohs Micrographic Surgery with Supplemental Lidocaine Jelly


About this study

The purpose of this study is to assess how using lidocaine jelly in Mohs surgery impacts the overall quantity of lidocaine/epinephrine injectable needed to maintain anesthesia, and patients’ pain/anxiety associated with anesthesia injections.   

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Patients undergoing Mohs surgery anywhere on the nose.

Exclusion Criteria:

  • Patients undergoing multiple Mohs surgeries in different anatomic locations on the same day (nose and ear, etc.).
  • Patients who are unable to consent to the study or who are unable to complete the questionnaire.
  • Patients with allergy to lidocaine.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Scottsdale/Phoenix, Ariz.

Mayo Clinic principal investigator

Shari Ochoa, M.D.

Closed for enrollment

Contact information:

Samantha Sagaser

(480) 301-6806

More information


Publications are currently not available

Study Results Summary

Not yet available

Supplemental Study Information

Not yet available


Mayo Clinic Footer